Riskpilot← Back to searchSign inGet full accessAGRI-Biotech Oy
OYDissolvedY-tunnus 2837662-4Långkärrvägen 12-AManufacture of other special-purpose machinery n.e.c. · NACE 2899Est. 2017— employees
Revenue 2024
EUR 0
EBITDA margin
—
-1848% vs 2022
Equity ratio
-49.2%
Financial strength
Net profit 2024
EUR -10K
-420% vs 2022
| Revenue | EUR 0 | — |
| EBITDA | EUR -8K | -1848% |
| Net profit | EUR -10K | -420% |
| Total assets | EUR 18K | +129% |
| Equity | EUR -9K | -240% |
| Employees | — | — |
Legal name
AGRI-Biotech Oy
Y-tunnus number
2837662-4
Legal form
Osakeyhtiö
NACE code
2899 · Manufacture of other special-purpose machinery n.e.c.
Founded
3. kesäkuuta 2017
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yleistoimiala
Address
Långkärrvägen 12-A
Phone
+358400562108
Email
harri.heiskanen@agri-biotech.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 12 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | −0 |
| EBITDA | −1 | −0 | −2 | 0 | −8 |
| Depreciation & amort. | — | −3 | — | −2 | −0 |
| EBIT | −1 | −3 | −2 | −2 | −8 |
| Net financials | −0 | −1 | — | — | −2 |
| Profit before tax | −1 | −4 | −2 | −2 | −10 |
| Tax | 1 | −1 | −0 | −0 | 0 |
| Net profit | −3 | −3 | −2 | −2 | −10 |
| Item | 2019 | 2020 | 2021 | 2022 | 2024 |
|---|---|---|---|---|---|
| Total assets | 17 | 14 | 11 | 8 | 18 |
| Equity | 13 | 10 | 8 | 6 | −9 |
| Long-term debt | — | — | — | — | 25 |
| Short-term debt | 4 | 4 | 2 | 2 | 2 |
| Total debt | 4 | 4 | 2 | 2 | 27 |
EBITDA margin
-772400.0%
This company
15.8%
Market median
-4888708% vs market
20192024
Equity ratio
-49.2%
This company
38.2%
Market median
-229% vs market
20192024
Return on equity
-1030000.0%
This company
18.4%
Market median
-5597926% vs market
20192024
Net profit margin
-1030000.0%
This company
8.1%
Market median
-12716149% vs market
20192024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192024
Debt / equity
3.03×
This company
0.62×
Market median
-389% vs market
20192024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HJ Deputy Member | Deputy Member | 2020 |
| Former (2) | ||
JA Deputy Member | Deputy Member | 2017 – 2020 |
MJ Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2023 | |
| Former (3) | ||
| Board of Directors | 2022 – 2023 | |
| Chairperson | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AGRI-Biotech Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Josefin Anna Daniela Schrey | Deputy Member | 0 companies |
| Heikki Juhani Seppä | Deputy Member | 0 companies |
| Marko Juhani Salminen | Chief Executive Officer | 0 companies |
| Kristian Jan Mikael Schrey | Board of Directors | 0 companies |
| Stefan Carl Fritiof Sandbacka | Chairperson | 0 companies |
| Pekka Tapio Jaatinen | Board of Directors | 0 companies |
| Harri Johannes Hermanni Heiskanen | Board of Directors | 0 companies |